Vertex Pharmaceuticals (VRTX) Cash from Operations Growth (1y) (2010 - 2026)
Vertex Pharmaceuticals (VRTX) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 356.73% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 158.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.39% |
| Dec 31, 2025 | -14.81% |
| Sep 30, 2025 | -9.37% |
| Jun 30, 2025 | 128.59% |
| Mar 31, 2025 | -37.33% |
| Dec 31, 2024 | 149.19% |
| Sep 30, 2024 | 7.99% |
| Jun 30, 2024 | -430.89% |
| Mar 31, 2024 | 45.19% |
| Dec 31, 2023 | -78.25% |
| Sep 30, 2023 | 32.75% |
| Jun 30, 2023 | -0.47% |
| Mar 31, 2023 | -5.89% |
| Dec 31, 2022 | 8.38% |
| Sep 30, 2022 | 3.05% |
| Jun 30, 2022 | 670.76% |
| Mar 31, 2022 | 3.82% |
| Dec 31, 2021 | 102.43% |
| Sep 30, 2021 | 2.14% |
| Jun 30, 2021 | -119.23% |